Dextromethorphan for OCD and related anxiety conditions
Treatments studied
Part of Mental health clinical trials.
This trial studies dextromethorphan, a medicine sometimes used for cough, to see if it can reduce symptoms in OCD and similar conditions. It may help people whose intrusive thoughts or related worries are still challenging despite current care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of OCD, body dysmorphic disorder (BDD), illness anxiety disorder (IAD), or somatic symptom disorder (SSD)
- You live in California
- You can understand the study and sign informed consent
- You do not currently have bipolar disorder or a psychotic disorder
- You do not have moderate or severe substance use problems (or a history of severe substance use problems)
- You are not pregnant and not nursing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether MDMA plus cognitive behavioral therapy (CBT) can reduce OCD symptoms in adults who have tried standard OCD treatments before. You may be asked to pause certain medicines and follow specific diet/medication rules around the study session.
This phase 2 study tests an OCD treatment strategy for people who have not yet had OCD medications or recent OCD therapy. It aims to reduce OCD symptoms, especially for those with moderate-to-severe symptom levels.
This study looks at how brain networks change before and after starting fluoxetine (an SSRI antidepressant) in people with obsessive-compulsive disorder (OCD). It also compares these brain scan patterns with people without OCD to help predict who may respond to treatment.
This trial tests a whole-mushroom version of psilocybin as a potential treatment for OCD that hasn't improved with standard therapies. Participants receive psilocybin in a controlled setting and are monitored closely for safety and changes in symptoms.
This study tests if a single dose of psilocybin, a psychedelic substance, can safely help people with obsessive-compulsive disorder (OCD) who have not responded well to standard treatments. If you have moderate to severe OCD and have tried at least one recommended treatment without success, you may be able to join.
This study tests a smartphone-based mindfulness program to help people with obsessive-compulsive disorder (OCD) reduce their symptoms. If you have OCD and are between 12 and 65 years old, you may be able to join.
Hear when a new Obsessive-Compulsive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.